Paul Jai Sekhri is an American businessperson who founded Cerimon Pharmaceuticals, Inc. and who has been the head of 13 different companies. Presently, he is Chairman of Compugen Ltd., Chairman for Pharming Group NV, Chairman at The Knights, Chairman at Longboard Pharmaceuticals, Inc., President, Chief Executive Officer & Director at vTv Therapeutics, Inc., Venture Partner at Medicxi Ventures (Jersey) Ltd., Advisor at Epidarex Capital Partners LLC, Advisor at Trialspark, Inc. and Chairman at Pharming NV.
He is also Member of Ontario Institute for Cancer Research and Managing Director & Operating Partner at Tarrant Capital IP LLC and on the board of 14 other companies.
He previously occupied the position of Chairman for moksha8 Pharmaceuticals, Inc., Chairman for Topas Therapeutics GmbH, President & Chief Executive Officer for Cerimon Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Lycera Corp., President & Chief Business Officer at ARIAD Pharmaceuticals, Inc., Chief Strategy Officer & EVP-Business Development at Teva Pharmaceutical Industries Ltd., Venture Partner at MPM Capital Inc, Partner-Healthcare Investments at New Leaf Venture Partners LLC, Member-Patrons Council at The Carnegie Hall Society, Inc., Chairman at Petra Pharma Corp., Partner at Sprout Group, Senior Vice President-Integrated Care at Sanofi, Inc., Operating Partner & Head-Biotechnology Operations at TPG Biotech Equity LP, Senior VP, Head-Global Search & Evaluation at Novartis Pharma AG, Senior Vice President-Integrated Care at Sanofi SA and Operating Partner at Highline Therapeutics, Inc.
Mr. Sekhri received an undergraduate degree from the University of Maryland and a graduate degree from the University of Maryland School of Medicine.